Avandia - MSN Newsfeeds
- Earthtimes - The incident involved a peer reviewer for The New England Journal of Medicine -- Steven Haffner of the University of Texas Health Science Center --who leaked a damaging study concerning GSK's diabetes drug Avandia (rosiglitazone) to the ...
- BusinessWeek - An unpublished, negative article about the diabetes drug Avandia was leaked to the drug's manufacturer before the article was published in the New England Journal of Medicine . Diabetes expert Dr. Steven M. Haffner of the University of Texas Health ...
- San Diego Union-Tribune - A Texas doctor leaked confidential research to the makers of the popular diabetes drug Avandia weeks before a study was published tying the drug to higher heart risks, the scientific journal Nature reported Wednesday. Dr. Steven Haffner, of the ...
- North County Times - A Texas doctor leaked confidential research to the makers of the popular diabetes drug Avandia weeks before a study was published tying the drug to higher heart risks, the scientific journal Nature reported Wednesday. Dr. Steven Haffner, of the ...
- Medical News Today - GlaxoSmithKline (GSK) announced that it will revise its European label for Avandia® (rosiglitazone maleate). The EMEA's Committee for Medicinal Products for Human Use (CHMP) completed a positive benefit risk review of the thiazolidinediones (TZDs ...
- Medical News Today - Recent studies that raised questions about the benefits of the cholesterol medication Vytorin, manufactured by Merck and Schering-Plough , and the safety of the type 2 diabetes treatment Avandia, manufactured by GlaxoSmithKline , are "reigniting ...
- St. Petersburg Times - Brownlee said he also "agreed to disagree" with the maker of Avandia, a diabetes drug, when criticized for talking too much about the disease and not enough about the product. And Brownlee said he held his ground when an AstraZeneca rep scolded him ...
- Taipei Times - The company's Avandia diabetes pill shouldn't be prescribed for patients with some heart conditions, European regulators said on Thursday. This story has been ...
- Bloomberg - The company's Avandia diabetes pill shouldn't be prescribed for patients with some heart conditions, European regulators said Jan. 24. Novozymes A/S, the world's biggest maker of enzymes for industrial and biofuel processes, slumped 16 ...
- Bloomberg - The company's Avandia diabetes pill shouldn't be prescribed for patients with some heart conditions, European regulators said Jan. 24. Novozymes A/S, the world's biggest maker of enzymes for industrial and biofuel processes, slumped 16 ...
- WebWire - GlaxoSmithKline (GSK) announced today that it will revise its European label for Avandia® (rosiglitazone maleate). The EMEA’s Committee for Medicinal Products for Human Use (CHMP) completed a positive benefit risk review of the thiazolidinediones ...
- Science News - So much for confidential peer review. Last May, a controversial paper in the New England Journal of Medicine ( NEJM ) reported that a popular diabetes drug—rosiglitazone, sold under the brand name Avandia—substantially hikes a user's risk of ...
- Forbes - The Law Offices of Howard G. Smith announces that an online sign up is available for a lawsuit on the behalf of people injured by taking Avandia. The suit will allege that the manufacturer of the drug, GlaxoSmithKline, failed to properly warn ...
- MSN MoneyCentral - Merck and Schering-Plough said today that they strongly object to mischaracterizations about the ENHANCE (Effect of Combination Ezetimibe and High-Dose Simvastatin vs. Simvastatin Alone on the Atherosclerotic Process in Patients with Heterozygous ...
- CNBC - ... 450 FirstGroup 647 down 20 Profit-taking after recent positive broker comment Sainsbury 379-1/2 down 12 Sector rotation Marks & Spencer 432 down 13 Sector rotation GlaxoSmithKline 1,198 down 17 More limits on diabetes drug Avandia ...
- Financial Times - GlaxoSmithKline , the UK-based pharmaceutical company headed by Jean-Pierre Garnier, has received a fresh blow to the prospects for Avandia, its diabetes drug, with European regulators imposing tighter restrictions on its use. The European Medicines ...
- WebMD - The diabetes drugs Avandia and Actos are the two members of a class of diabetes drug known as the glitazones. (Avandaryl and Avandamet are combination drugs containing Avandia; Duetact is a combination drug containing Actos.) The state-of-the-art ...
- Reuters - LONDON (Reuters) - European regulators on Thursday recommended that patients with heart disease or leg pains -- a possible sign of heart problems -- should not take GlaxoSmithKline's diabetes drug Avandia. The European Medicines Agency also said in ...
- Phramalive.com - LONDON, Jan. 24, 2008-On 24 January 2008 the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion ** to recommend the variation to the terms of the marketing authorisation for the medicinal product Avandia. The Marketing ...
- Phramalive.com - rosiglitazone / glimepiride LONDON, Jan. 24, 2008-On 24 January 2008 the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion ** to recommend the variation to the terms of the marketing authorisation for the medicinal ...
Want to contact a District of Columbia Avandia attorney? ...Get a free case evaluation from one of our District of Columbia Avandia attorneys now.
Pages: Previous 1 2 3 4 5 6 7 8 9 10 11 ... Next
This form is secure and encrypted. More information about secure forms and your privacy here.
Avandia Case Evaluation Form
